Cargando…
A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy
PURPOSE: Although somatostatin receptor (SST) is a promising theranostic target and is widely expressed in tumors of various organs, the indication for therapies targeting SST is limited to typical gastroenteropancreatic neuroendocrine tumors (NETs). Thus, broadening the scope of the current clinica...
Autores principales: | Lee, Hyunjong, Suh, Minseok, Choi, Hongyoon, Ha, Seunggyun, Paeng, Jin Chul, Cheon, Gi Jeong, Kang, Keon Wook, Lee, Dong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183516/ https://www.ncbi.nlm.nih.gov/pubmed/32335823 http://dx.doi.org/10.1186/s13550-020-00632-2 |
Ejemplares similares
-
Phase 1 Study of No-Carrier Added (177)Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea
por: Ryoo, Hyun Gee, et al.
Publicado: (2023) -
Fully automated identification of brain abnormality from whole-body FDG-PET imaging using deep learning-based brain extraction and statistical parametric mapping
por: Whi, Wonseok, et al.
Publicado: (2021) -
Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022) -
Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer
por: Suh, Hoon Young, et al.
Publicado: (2019) -
FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization
por: Suh, Hoon Young, et al.
Publicado: (2023)